BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3466948)

  • 1. Effect of spironolactone on renal prostaglandin excretion in patients with liver cirrhosis and ascites.
    Medina JF; Prieto J; Guarner F; Quiroga J; Milazzo A
    J Hepatol; 1986; 3(2):206-11. PubMed ID: 3466948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal prostaglandins in cirrhosis of the liver.
    Guarner C; Colina I; Guarner F; Corzo J; Prieto J; Vilardell F
    Clin Sci (Lond); 1986 May; 70(5):477-84. PubMed ID: 3516533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of 6-keto-prostaglandin F1 alpha, thromboxane B2 and prostaglandin E2 in cirrhosis with ascites. Relationship to functional renal failure (hepatorenal syndrome).
    Rimola A; Ginés P; Arroyo V; Camps J; Pérez-Ayuso RM; Quintero E; Gaya J; Rivera F; Rodés J
    J Hepatol; 1986; 3(1):111-7. PubMed ID: 3462243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulindac reduces the urinary excretion of prostaglandins and impairs renal function in cirrhosis with ascites.
    Quintero E; Ginés P; Arroyo V; Rimola A; Camps J; Gaya J; Guevara A; Rodamilans M; Rodés J
    Nephron; 1986; 42(4):298-303. PubMed ID: 3515219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered renal and platelet arachidonic acid metabolism in cirrhosis.
    Laffi G; La Villa G; Pinzani M; Ciabattoni G; Patrignani P; Mannelli M; Cominelli F; Gentilini P
    Gastroenterology; 1986 Feb; 90(2):274-82. PubMed ID: 3079716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced excretion of vasodilator prostaglandins in preeclampsia.
    Minuz P; Covi G; Corsato M; Probitzer P; Spiazzi L; Paluani F; Degan M; Lechi C; Lechi A
    Agents Actions Suppl; 1987; 22():175-81. PubMed ID: 3324706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
    Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
    Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary prostaglandin E2 excretion, sodium retention, and diuretic responsiveness in patients with chronic liver disease.
    Rector WG
    Am J Gastroenterol; 1987 Apr; 82(4):347-51. PubMed ID: 3471082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian rhythm of PGE2, PGF2 alpha and 6-keto-PGF1 alpha urinary excretion in healthy women.
    Ignatowska-Switalska H
    Prostaglandins Leukot Med; 1983 Jun; 11(2):233-40. PubMed ID: 6576390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urinary prostaglandins in the hepatorenal syndrome of cirrhotic patients: role of thromboxane A2 and an imbalance of precursor polyunsaturated fatty acids].
    Parelon G; Mirouze D; Michel F; Crastes de Paulet P; Chaintreuil J; Crastes de Paulet A; Michel H
    Gastroenterol Clin Biol; 1985 Apr; 9(4):290-7. PubMed ID: 3996812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volume-induced natriuresis in healthy women: renal metabolism of prostacyclin and thromboxane, and physiological role of prostanoids.
    Agnoli GC; Borgatti R; Cacciari M; Lenzi P; Marinelli M; Stipo L
    Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):95-103. PubMed ID: 11237476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal study of renal prostaglandin excretion in cirrhotic rats: relationship with the renin-aldosterone system.
    Solà J; Camps J; Arroyo V; Guarner F; Gaya J; Rivera F; Rodes J
    Clin Sci (Lond); 1988 Sep; 75(3):263-9. PubMed ID: 3046823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal hemodynamics and urinary excretion of 6-keto-prostaglandin F1 alpha and thromboxane B2 in newly diagnosed type I diabetic patients.
    Gambardella S; Andreani D; Cancelli A; Di Mario U; Cardamone I; Stirati G; Cinotti GA; Pugliese F
    Diabetes; 1988 Aug; 37(8):1044-8. PubMed ID: 3391343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between urinary prostaglandin (PGE2 and PGF2 alpha) and sodium excretion in various stages of chronic liver disease.
    Wernze H; Müller G; Goerig M
    Adv Prostaglandin Thromboxane Res; 1980; 7():1089-96. PubMed ID: 7369021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
    Patrono C; Ciabattoni G; Remuzzi G; Gotti E; Bombardieri S; Di Munno O; Tartarelli G; Cinotti GA; Simonetti BM; Pierucci A
    J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrarenal thromboxane A2 generation reduces the furosemide-induced sodium and water diuresis in cirrhosis with ascites.
    Pinzani M; Laffi G; Meacci E; La Villa G; Cominelli F; Gentilini P
    Gastroenterology; 1988 Oct; 95(4):1081-7. PubMed ID: 3165896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II-induced hypertension in the rat. Effects on the plasma concentration, renal excretion, and tissue release of prostaglandins.
    Diz DI; Baer PG; Nasjletti A
    J Clin Invest; 1983 Aug; 72(2):466-77. PubMed ID: 6575977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation of effects of xanthine analogs on renal prostaglandins and renal excretory function in the awake rat.
    Baer PG; Armstrong EL; Cagen LM
    J Pharmacol Exp Ther; 1983 Dec; 227(3):600-4. PubMed ID: 6581288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma.
    Aitokallio-Tallberg AM; Jung JK; Kim SJ; Viinikka LU; Ylikorkala RO
    Cancer Res; 1991 Aug; 51(16):4146-8. PubMed ID: 1868436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tienoxolol, a new diuretic beta-blocking agent, on urinary prostaglandin excretion in the rat.
    Caussade F; Cloarec A
    Br J Pharmacol; 1993 May; 109(1):278-84. PubMed ID: 8098641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.